Extracapsular dissection versus superficial parotidectomy in pleomorphic adenoma: a decade-long experience from a tertiary care center in Bangladesh
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20251498Keywords:
Parotidectomy, Pleomorphic adenoma, Superficial parotidectomy, Parotid gland tumors, Facial nerve preservationAbstract
Background: Pleomorphic adenoma is recognized as the most common benign tumor of the salivary glands, while malignant tumors like mucoepidermoid carcinoma, though less frequent, present complex management challenges. This study aims to evaluate the efficacy and safety of surgical techniques, specifically extracapsular dissection (ECD) and superficial parotidectomy (SP), in Bangladesh, where data on this topic is limited.
Methods: Conducted over ten years (2014-2024) at the national center for hearing and speech for children and green life medical college and hospital, this retrospective cohort study analyzed records of 50 patients with histopathologically confirmed pleomorphic adenoma. Data included demographics, tumor characteristics, and surgical outcomes, with statistical significance set at p<0.05.
Results: The cohort had a median age of 38 years, predominantly female (58%). The median tumor size was 4 cm, with most surgeries on the right side (52%). Preoperative diagnoses indicated 79.07% pleomorphic adenomas, with FNAC confirming 84.44% benign lesions. ECD was associated with larger tumors (mean size: 7.82 cm vs. 5.65 cm, p=0.0459) and a higher malignancy rate. Facial nerve preservation rates were 73.33% for ECD and 80.65% for SP. However, ECD had a higher complication rate, including temporary facial nerve paralysis (57.14% vs. 15.38%) and seroma formation (14.29% vs. 0%, p=0.021).
Conclusions: This study underscores that pleomorphic adenoma is the predominant parotid gland pathology in Bangladesh. Both ECD and SP are effective surgical options, but careful planning and patient selection are crucial to minimize complications and enhance outcomes.
Metrics
References
El Sayed Ahmad Y, Winters R. Parotidectomy 2024. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025.
Kuan EC, Mallen-St J. Clair, John MAS. Evaluation of Parotid Lesions. Otolaryngologic Clin N Am. 2016;49(2):313-25. DOI: https://doi.org/10.1016/j.otc.2015.10.004
Bly RA, Holdefer RN, Slimp J, Kinney GA, Martinez VA, Manning SC, et al. Preoperative Facial Nerve Mapping to Plan and Guide Pediatric Facial Vascular Anomaly Resection. JAMA Otolaryngol Head Neck Surg. 2018;144(5):418-26. DOI: https://doi.org/10.1001/jamaoto.2018.0054
Gawand S, Gattani RG, Kumar CA, Pande A. Extracapsular Dissection Versus Traditional Parotid Surgery: A Comprehensive Review of Techniques and Outcomes. Cureus. 2024;16(9):e69141. DOI: https://doi.org/10.7759/cureus.69141
Kato MG, Erkul E, Nguyen SA. Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis. JAMA Otolaryngol Head Neck Surg. 2017;143(11):1092-7. DOI: https://doi.org/10.1001/jamaoto.2017.1618
Mckenzie J, Lockyer J, Singh T, Nguyen E. Salivary gland tumours: an epidemiological review of non-neoplastic and neoplastic pathology. Brit J Oral Maxillofacial Surg. 2023;61(1):12-8. DOI: https://doi.org/10.1016/j.bjoms.2022.11.281
Young A, Okuyemi OT. Malignant Salivary Gland Tumors. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025.
Mayera M, Thoelkena R, Jeringa M, Märklb B, Agaimyc A, Zenk J. Pleomorphic adenoma of the parotid gland presenting as extensively ossified lesion with bone infiltration: a case report. Braz J Otorhinolaryngol. 2022;88(54):S215-8. DOI: https://doi.org/10.1016/j.bjorl.2021.07.014
Bussu F, Parrilla C, Rizzo D, Almadori G, Paludetti G, Galli J. Clinical Approach And Treatment Of Benign And Malignant Parotid Masses, Personal Experience. Acta Otorhinolaryngol Ital. 2011;31(3):135-43.
Lee DH, Jung EK, Lee JK, Lim SC. Comparative analysis of benign and malignant parotid gland tumors: A retrospective study of 992 patients. Am J Otolaryngol. 2023;44(2):103690. DOI: https://doi.org/10.1016/j.amjoto.2022.103690
Massimilla EA, Motta G, Magaldi M, Montella M, Messina G, Testa D, et al. Minimal Margin Surgery and Intraoperative Neuromonitoring in Benign Parotid Gland Tumors: Retrospective Clinical Study. J Pers Med. 2022;12(10):1641. DOI: https://doi.org/10.3390/jpm12101641
Bokhari MR, Greene J. Pleomorphic Adenoma. StatPearls. Treasure Island (FL): StatPearls Publishing. 2023.
Bettini R, Partelli S, Boninsegna L, Capelli P, Crippa S, Pederzoli P, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery. 2011;150(1). DOI: https://doi.org/10.1016/j.surg.2011.02.022
De Meira NS, Meira CLS, Pereira YDS, De Castro Moraes J, Daroz BG, Da Silva BBP, et al. Pleomorphic adenoma of parotid gland: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;134(3):e181. DOI: https://doi.org/10.1016/j.oooo.2022.01.535
Mendoza P, Lacambra M, Tan PH, Tse GM. Fine Needle Aspiration Cytology of the Breast: The Nonmalignant Categories. Patholog Res Int. 2011;2011:547580. DOI: https://doi.org/10.4061/2011/547580
Alqaryan S, Aldokhayel F, Alotaibi M, Alnasser A, Alabdulqader A, Alessa M, et al. Factors Associated With Postoperative Complications in Patients Who Underwent Parotidectomy: A Retrospective Study. Ear Nose Throat J. 2024;1455613241244656. DOI: https://doi.org/10.1177/01455613241244656
Rahman SS, Hossain MI, Nasreen S, Ahamad MU, Bhattecharjee P, Rahman Z, et al. Malignant Solid Childhood Tumors: Morphological Study in a Tertiary Hospital. J Histopathol Cytopathol. 2020;4(1):3-11.
Wu SJ, Wu CY, Ye K. Risk factors, monitoring, and treatment strategies for early recurrence after rectal cancer surgery. World J Gastrointest Surg. 2025;17(1):100232. DOI: https://doi.org/10.4240/wjgs.v17.i1.100232
Downloads
Published
How to Cite
Issue
Section
